Javascript must be enabled to continue!
Hematological parameters of newborns from diabetic mothers in Gandhi memorial hospital, Addis Ababa, Ethiopia
View through CrossRef
Background
Diabetes mellitus during pregnancy can significantly affect a newborn’s hematological profile. However, the hematological profiles among newborns of diabetic mothers and their clinical and prognostic implications are not well explored. Therefore, this study aimed to determine hematological parameters of newborns from diabetic mothers in Gandhi Memorial Hospital, Addis Ababa, Ethiopia, 2024.
Methods
A comparative cross-sectional study was carried out at Gandhi Memorial Hospital from March to May 2024. A total of 196 newborns -98 from diabetic mothers and 98 from apparently healthy mothers—were conveniently enrolled in the study. A hematological profile test was assayed using a Sysmex XN-550 analyzer from the whole blood of mothers and cord blood of newborns collected in EDTA. Glucose was measured using a Cobas C311 analyzer from serum collected using SST test tube. Data was entered and analyzed using SPSS version 26, with descriptive statistics, proportions, and independent t-tests. A P-value of less than 0.05 was considered statistically significant.
Results
The study found that the mean ± SD value of red blood cell count was 4.87 ± 0.68 vs 3.33 ± 0.98 x1012/L (P < 0.001), hemoglobin 17.48 ± 2.69 vs 12.08 ± 3.48 g/dL (P < 0.001), hematocrit 49.83 ± 7.47 vs 36.13 ± 8.97% (P < 0.001), red cell distribution width 18.35 ± 2.68 vs 17.27 ± 1.92% (P < 0.001), platelet distribution width 12.26 ± 1.80 vs 11.69 ± 1.76% (P = 0.028), and platelet large cell ratio was 26.05 ± 5.27 vs 24.07 ± 2.21% (P = 0.001) were significantly higher in newborns born to diabetic mothers compared to controls. Polycythemia was seen in large numbers in newborns born to diabetic mothers (56.1%, 55/98 vs 1%, 1/98). On the other hand, the platelet count and PCT values were significantly lower in newborns from diabetic mothers than controls, with a mean value of 239.69 ± 92.52 (103/µL) and 0.24 ± 0.09 (%), respectively, with a P value < 0.001.
Conclusion
The hematological profile shows a significant difference among newborns from mothers with diabetes and apparently healthy mothers. Therefore, it is better to consider hematological parameters as a screening tool for early detection of hematological complications in newborns from diabetic mothers, and this screening should be encouraged.
Public Library of Science (PLoS)
Title: Hematological parameters of newborns from diabetic mothers in Gandhi memorial hospital, Addis Ababa, Ethiopia
Description:
Background
Diabetes mellitus during pregnancy can significantly affect a newborn’s hematological profile.
However, the hematological profiles among newborns of diabetic mothers and their clinical and prognostic implications are not well explored.
Therefore, this study aimed to determine hematological parameters of newborns from diabetic mothers in Gandhi Memorial Hospital, Addis Ababa, Ethiopia, 2024.
Methods
A comparative cross-sectional study was carried out at Gandhi Memorial Hospital from March to May 2024.
A total of 196 newborns -98 from diabetic mothers and 98 from apparently healthy mothers—were conveniently enrolled in the study.
A hematological profile test was assayed using a Sysmex XN-550 analyzer from the whole blood of mothers and cord blood of newborns collected in EDTA.
Glucose was measured using a Cobas C311 analyzer from serum collected using SST test tube.
Data was entered and analyzed using SPSS version 26, with descriptive statistics, proportions, and independent t-tests.
A P-value of less than 0.
05 was considered statistically significant.
Results
The study found that the mean ± SD value of red blood cell count was 4.
87 ± 0.
68 vs 3.
33 ± 0.
98 x1012/L (P < 0.
001), hemoglobin 17.
48 ± 2.
69 vs 12.
08 ± 3.
48 g/dL (P < 0.
001), hematocrit 49.
83 ± 7.
47 vs 36.
13 ± 8.
97% (P < 0.
001), red cell distribution width 18.
35 ± 2.
68 vs 17.
27 ± 1.
92% (P < 0.
001), platelet distribution width 12.
26 ± 1.
80 vs 11.
69 ± 1.
76% (P = 0.
028), and platelet large cell ratio was 26.
05 ± 5.
27 vs 24.
07 ± 2.
21% (P = 0.
001) were significantly higher in newborns born to diabetic mothers compared to controls.
Polycythemia was seen in large numbers in newborns born to diabetic mothers (56.
1%, 55/98 vs 1%, 1/98).
On the other hand, the platelet count and PCT values were significantly lower in newborns from diabetic mothers than controls, with a mean value of 239.
69 ± 92.
52 (103/µL) and 0.
24 ± 0.
09 (%), respectively, with a P value < 0.
001.
Conclusion
The hematological profile shows a significant difference among newborns from mothers with diabetes and apparently healthy mothers.
Therefore, it is better to consider hematological parameters as a screening tool for early detection of hematological complications in newborns from diabetic mothers, and this screening should be encouraged.
Related Results
Neonatal mortality and associated factors among neonates admitted to neonatal intensive care unit of Gandhi memorial hospital in Addis Ababa, Ethiopia, 2019
Neonatal mortality and associated factors among neonates admitted to neonatal intensive care unit of Gandhi memorial hospital in Addis Ababa, Ethiopia, 2019
Abstract
Background
Ethiopia witnessed an unprecedented decline in under-5 and neonatal mortalities since 2000. But, neonatal mortality still accoun...
Incidence and Pattern of Childhood Cancer in Addis Ababa, Ethiopia (2012 - 2017)
Incidence and Pattern of Childhood Cancer in Addis Ababa, Ethiopia (2012 - 2017)
AbstractBackgroundCancer is becoming a major public health problem and a leading cause of death in children worldwide. However, little is known about the epidemiology of childhood ...
Determinants of stock-outs of first line anti-tuberculosis drugs: the case of public health facilities of Addis Ababa city administration health bureau, Addis Ababa, Ethiopia
Determinants of stock-outs of first line anti-tuberculosis drugs: the case of public health facilities of Addis Ababa city administration health bureau, Addis Ababa, Ethiopia
Abstract
Background
The health sectors success has been determined by consistent and reasonably priced health commodities supply. Despite possible d...
Maternal cigarette smoking and its effect on neonatal lymphocyte subpopulations and replication
Maternal cigarette smoking and its effect on neonatal lymphocyte subpopulations and replication
AbstractBackgroundSignificant immunomodulatory effects have been described as result of cigarette smoking in adults and pregnant women. However, the effect of cigarette smoking dur...
THE IMPACT ON THE STATE OF HEALTH DUE TO THE SEPARATION OF MOTHER/INFANT
THE IMPACT ON THE STATE OF HEALTH DUE TO THE SEPARATION OF MOTHER/INFANT
Introduction: Early maternal/infant separation can result in a series of traumatic emotional reactions from both the newborn and the mother. Material and methods: The authors propo...
EVALUATION OF VITAMIN D IN MOTHERS AND NEWBORNS AT BIRTH IN SULAIMANI MATERNITY TEACHING HOSPITAL
EVALUATION OF VITAMIN D IN MOTHERS AND NEWBORNS AT BIRTH IN SULAIMANI MATERNITY TEACHING HOSPITAL
BackgroundDeficiencies in vitamin D are frequent worldwide. Approximately 1 billion individuals around the globe are vitamin D deficient (<20ng/ml), and half of the population i...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract
Introduction
Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Hematological, clinical, cytogenetic and molecular profiles of confirmed chronic myeloid leukemia patients at presentation at a tertiary care teaching hospital in Addis Ababa, Ethiopia: a cross-sectional study
Hematological, clinical, cytogenetic and molecular profiles of confirmed chronic myeloid leukemia patients at presentation at a tertiary care teaching hospital in Addis Ababa, Ethiopia: a cross-sectional study
Abstract
Background
In low-income countries there is insufficient evidence on hematological, clinical, cytogenetic and molecular profiles among new ...


